CIBC Asset Management’s Sarepta Therapeutics SRPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,851
| Closed | -$347K | – | 1240 |
|
|
2024
Q4 | $347K | Buy |
2,851
+139
| +5% | +$16.9K | ﹤0.01% | 830 |
|
|
2024
Q3 | $339K | Buy |
2,712
+86
| +3% | +$10.7K | ﹤0.01% | 838 |
|
|
2024
Q2 | $415K | Buy |
2,626
+316
| +14% | +$49.9K | ﹤0.01% | 761 |
|
|
2024
Q1 | $299K | Hold |
2,310
| – | – | ﹤0.01% | 832 |
|
|
2023
Q4 | $223K | Hold |
2,310
| – | – | ﹤0.01% | 935 |
|
|
2023
Q3 | $280K | Hold |
2,310
| – | – | ﹤0.01% | 814 |
|
|
2023
Q2 | $265K | Hold |
2,310
| – | – | ﹤0.01% | 841 |
|
|
2023
Q1 | $318K | Buy |
2,310
+49
| +2% | +$6.75K | ﹤0.01% | 787 |
|
|
2022
Q4 | $293K | Sell |
2,261
-124,714
| -98% | -$16.2M | ﹤0.01% | 820 |
|
|
2022
Q3 | $14M | Buy |
126,975
+123,961
| +4,113% | +$13.7M | 0.06% | 174 |
|
|
2022
Q2 | $226K | Sell |
3,014
-193,955
| -98% | -$14.5M | ﹤0.01% | 1032 |
|
|
2022
Q1 | $15.4M | Hold |
196,969
| – | – | 0.05% | 185 |
|
|
2021
Q4 | $17.7M | Sell |
196,969
-108,162
| -35% | -$9.74M | 0.06% | 170 |
|
|
2021
Q3 | $28.2M | Buy |
305,131
+30,751
| +11% | +$2.84M | 0.11% | 126 |
|
|
2021
Q2 | $21.3M | Buy |
274,380
+271,466
| +9,316% | +$21.1M | 0.09% | 139 |
|
|
2021
Q1 | $217K | Buy |
2,914
+118
| +4% | +$8.79K | ﹤0.01% | 1190 |
|
|
2020
Q4 | $477K | Hold |
2,796
| – | – | ﹤0.01% | 761 |
|
|
2020
Q3 | $393K | Buy |
2,796
+69
| +3% | +$9.7K | ﹤0.01% | 753 |
|
|
2020
Q2 | $437K | Hold |
2,727
| – | – | ﹤0.01% | 712 |
|
|
2020
Q1 | $267K | Hold |
2,727
| – | – | ﹤0.01% | 767 |
|
|
2019
Q4 | $352K | Buy |
+2,727
| New | +$352K | ﹤0.01% | 812 |
|
|
2019
Q3 | – | Sell |
-2,317
| Closed | -$352K | – | 1151 |
|
|
2019
Q2 | $352K | Hold |
2,317
| – | – | ﹤0.01% | 799 |
|
|
2019
Q1 | $276K | Hold |
2,317
| – | – | ﹤0.01% | 869 |
|
|
2018
Q4 | $253K | Hold |
2,317
| – | – | ﹤0.01% | 840 |
|
|
2018
Q3 | $374K | Hold |
2,317
| – | – | ﹤0.01% | 782 |
|
|
2018
Q2 | $306K | Buy |
+2,317
| New | +$306K | ﹤0.01% | 822 |
|